Skip to main content

MoneyWorks4Me

Marksans Pharma board informs about appointment of Additional Director

31 Oct 2013 Evaluate

Marksans Pharma has informed that the Board of Directors of the Company at its meeting held on October 31, 2013, appointed Naresh Balwant Wadhwa as an additional Director of the Company. Wadhwa will be an independent non-executive director.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1878.45
Dr. Reddys Labs. 1378.50
Cipla 1397.60
Lupin 1984.00
Zydus Lifesciences 1189.50
View more..